GreenLight Biosciences

Executive Summary

GreenLight Biosciences is a U.S.-based biotechnology company pioneering RNA-based solutions for sustainable agriculture. Founded in 2008 and headquartered in Medford, Massachusetts, the company leverages its proprietary RNA production platform to develop targeted, environmentally friendly crop protection products as alternatives to traditional chemical pesticides. Its pipeline includes insecticides, fungicides, and herbicides that are highly selective and rapidly biodegradable, addressing the growing demand for sustainable farming practices. While GreenLight is still in the development stage, its approach has significant potential to reduce the environmental impact of agriculture while maintaining crop yields. The company operates in a competitive landscape but differentiates itself through its scalable, low-cost RNA manufacturing technology. With increasing regulatory support for biological pesticides and rising consumer preference for eco-friendly products, GreenLight is well-positioned to capture market share if it successfully commercializes its lead candidates. However, the company remains private and has yet to achieve commercial revenue, implying higher risk but also significant upside if its RNA platform proves effective and cost-competitive.

Upcoming Catalysts (preview)

• Q3 2026Regulatory approval of first RNA-based insecticide60% success
• Q4 2026Series C or D funding round to scale manufacturing70% success
• Q1 2027Strategic partnership with major agrochemical company50% success